Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026.
- The company raised its revenue guidance for fiscal 2025 to at least $400.0 billion from the earlier forecast of $397.3 billion
- The outlook for FY25 adjusted earnings per share has been increased to $6.60-$6.70 from $6.55-$6.65 estimated earlier
- It also reaffirmed its fiscal 2025 cash flow from operations guidance range of $7.5 billion to $8.0 billion
- For fiscal 2026, the management forecasts total revenues of at least $400.0 billion
- It sees FY26 earnings per share in the range of $5.94 to $6.14, and adjusted earnings per share between $7.00 and $7.20
- FY26 operating income is expected to be in the range of $13.26 billion to $13.60 billion, and adjusted operating income in the $15.07-$15.41 billion range
- Cash flow from operations is expected to be at least $10.0 billion in fiscal 2026
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a